Relevance of p185 HER-2/neu oncoprotein quantification in human primary breast carcinoma

By Bermont L.  

Breast Cancer Research and Treatment, Vol. 63, Iss. 2, 2000-09 ,pp. : 163-169

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu Assessment in Primary Chemotherapy Treated Breast Carcinoma: No Evidence of Gene Profile Changing

By Dagrada G.P.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 2, 2003-07 ,pp. : 207-214

Springer Publishing Company

Access to resources Recommend Favorite

Pre-existent immunity to the HER-2/neu oncogenic protein in patients with HER-2/neu overexpressing breast and ovarian cancer

By Disis M.L.   Knutson K.L.   Schiffman K.   Rinn K.   McNeel D.G.  

Breast Cancer Research and Treatment, Vol. 62, Iss. 3, 2000-08 ,pp. : 245-252

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/neu overexpression and in vitro chemosensitivity to CMF and FEC in primary breast cancer

By Konecny G.  

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 53-63

Springer Publishing Company

Access to resources Recommend Favorite

Co-Expression of ErbB-Family Members in Human Breast Cancer: Her-2/neu is the Preferred Dimerization Candidate in Nodal-positive Tumors

By Hudelist G.  

Breast Cancer Research and Treatment, Vol. 80, Iss. 3, 2003-08 ,pp. : 353-361

Springer Publishing Company

Access to resources Recommend Favorite